PCa tissues; benign prostatic hyperplasia tissues; tumor xenograft tissues
C4-2; PC3; 22Rv1; DU145; LNCaP; RWPE-1
cell line-derived xenograft
ceRNA regulation (other); proliferation (inhibits); migration (inhibits); invasion (inhibits); metastasis (inhibits); PI3K/AKT/mTOR (inhibits)
RT-qPCR; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Wound Healing Assay; Transwell Assay; IHC (Immunohistochemistry); Nuclear-Cytoplasmic Fractionation; FISH / smFISH; Bioinformatics Analysis; RNA Pull-Down; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); In Vivo Animal Model
Low hsa_circ_0007494 expression was linked to metastasis and advanced tumor stage in PCa patients; hsa_circ_0007494 may be a treatment target for PCa.
Hsa_circ_0007494 is down-regulated in prostate cancer tissues and cell lines, and low expression is associated with metastasis and advanced tumor stage. Functionally, hsa_circ_0007494 acts as a tumor suppressor by inhibiting PCa cell proliferation, migration, invasion, and xenograft tumor growth. Mechanistically, it sponges miR-616 to upregulate PTEN, forming the hsa_circ_0007494/miR-616/PTEN axis.
0.8032
Hsa_circ_0007494 suppresses prostate cancer progression via miR-616/PTEN axis.
combined biological and clinical study